| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 18231543
[patent_doc_number] => RE049443
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-03-07
[patent_title] => Process for producing a stable low concentration, injectable solution of noradrenaline
[patent_app_type] => reissue
[patent_app_number] => 17/006838
[patent_app_country] => US
[patent_app_date] => 2020-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3661
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006838
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/006838 | Process for producing a stable low concentration, injectable solution of noradrenaline | Aug 29, 2020 | Issued |
Array
(
[id] => 17920922
[patent_doc_number] => RE049238
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-10-11
[patent_title] => Alleviating oxidative stress disorders with PUFA derivatives
[patent_app_type] => reissue
[patent_app_number] => 16/997692
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 16836
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997692 | Alleviating oxidative stress disorders with PUFA derivatives | Aug 18, 2020 | Issued |
| 90/014537 | LIPIDS CONTAINING OMEGA-3 AND OMEGA-6 FATTY ACIDS | Jun 24, 2020 | Issued |
| 16/866241 | PREPARATION AND COMPOSITION OF INTER-ALPHA INHIBITOR PROTEINS FROM HUMAN PLASMA FOR THERAPEUTIC USE | May 3, 2020 | Abandoned |
Array
(
[id] => 16555783
[patent_doc_number] => 20210000931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => COMPOSITIONS AND METHODS OF USE FOR ALPHA-1 ANTITRYPSIN HAVING NO SIGNIFICANT SERINE PROTEASE INHIBITOR ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/855957
[patent_app_country] => US
[patent_app_date] => 2020-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16855957
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/855957 | COMPOSITIONS AND METHODS OF USE FOR ALPHA-1 ANTITRYPSIN HAVING NO SIGNIFICANT SERINE PROTEASE INHIBITOR ACTIVITY | Apr 21, 2020 | Abandoned |
| 96/000324 | MINI-GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN CCK2 RECEPTOR POSITIVE TUMOUR DIAGNOSIS AND/OR TREATMENT | Apr 19, 2020 | Pending |
Array
(
[id] => 18011482
[patent_doc_number] => RE049304
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-11-22
[patent_title] => Compositions and method for multiplex biomarker profiling
[patent_app_type] => reissue
[patent_app_number] => 16/840107
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 47
[patent_no_of_words] => 39176
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/840107 | Compositions and method for multiplex biomarker profiling | Apr 2, 2020 | Issued |
| 90/014480 | MEDICINAL COMPOSITION OF AMARANTH EXTRACT ORIGIN HAVING ENRICHED NITRATE CONTENT AND A METHOD OF PREPARING THE SAME | Mar 23, 2020 | Issued |
Array
(
[id] => 17996069
[patent_doc_number] => RE049294
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-11-15
[patent_title] => DNA vector production system
[patent_app_type] => reissue
[patent_app_number] => 16/810504
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 9
[patent_no_of_words] => 13185
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16810504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/810504 | DNA vector production system | Mar 4, 2020 | Issued |
Array
(
[id] => 17903718
[patent_doc_number] => RE049229
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-10-04
[patent_title] => Methods and compositions for treating malignant tumors associated with KRAS mutation
[patent_app_type] => reissue
[patent_app_number] => 16/804696
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17528
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/804696 | Methods and compositions for treating malignant tumors associated with KRAS mutation | Feb 27, 2020 | Issued |
| 90/014445 | Protease-deficient mutants of Trichoderma for producing polypeptides | Feb 2, 2020 | Issued |
Array
(
[id] => 18027181
[patent_doc_number] => RE049311
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-11-29
[patent_title] => None
[patent_app_type] => reissue
[patent_app_number] => 16/749275
[patent_app_country] => US
[patent_app_date] => 2020-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 29906
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16749275
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/749275 | None | Jan 21, 2020 | Issued |
Array
(
[id] => 17539239
[patent_doc_number] => RE049037
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-04-19
[patent_title] => Broadly neutralizing antibody and uses thereof
[patent_app_type] => reissue
[patent_app_number] => 16/726453
[patent_app_country] => US
[patent_app_date] => 2019-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 19912
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16726453
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/726453 | Broadly neutralizing antibody and uses thereof | Dec 23, 2019 | Issued |
Array
(
[id] => 17539237
[patent_doc_number] => RE049035
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-04-19
[patent_title] => Traditional Chinese medicine composition, and preparation and application thereof
[patent_app_type] => reissue
[patent_app_number] => 16/715485
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 17453
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715485
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/715485 | Traditional Chinese medicine composition, and preparation and application thereof | Dec 15, 2019 | Issued |
| 96/000305 | MESENCHYMAL STEM CELL AND A METHOD OF USE THEREOF | Dec 15, 2019 | Pending |
Array
(
[id] => 17973710
[patent_doc_number] => RE049281
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-11-08
[patent_title] => Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors
[patent_app_type] => reissue
[patent_app_number] => 16/713457
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30403
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/713457 | Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors | Dec 12, 2019 | Issued |
Array
(
[id] => 17554302
[patent_doc_number] => RE049050
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-04-26
[patent_title] => Traditional Chinese medicine composition, and preparation and application thereof
[patent_app_type] => reissue
[patent_app_number] => 16/713533
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 18423
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713533
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/713533 | Traditional Chinese medicine composition, and preparation and application thereof | Dec 12, 2019 | Issued |
| 16/702978 | METHOD FOR PRODUCING NATURAL KILLER CELLS, NATURAL KILLER CELLS PRODUCED THEREBY, AND COMPOSITION FOR TREATING CANCERS AND INFECTIOUS DISEASES CONTAINING THE SAME | Dec 3, 2019 | Abandoned |
Array
(
[id] => 17191467
[patent_doc_number] => RE048801
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2021-11-02
[patent_title] => Inhibition of a lncRNA for treatment of melanoma
[patent_app_type] => reissue
[patent_app_number] => 16/689648
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 34
[patent_no_of_words] => 9276
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689648
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/689648 | Inhibition of a lncRNA for treatment of melanoma | Nov 19, 2019 | Issued |
Array
(
[id] => 17857909
[patent_doc_number] => RE049207
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-09-13
[patent_title] => Transposase-random priming DNA sample preparation
[patent_app_type] => reissue
[patent_app_number] => 16/678868
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 10712
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678868
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/678868 | Transposase-random priming DNA sample preparation | Nov 7, 2019 | Issued |